TXHD Last trade .0006. Easy 10 bagger! DD:

New Post Public Reply Private Reply Replies (0) Message Board
makebucks
148
TXHD Last trade .0006. Easy 10 bagger! DD: www.textmunication.com
Textmunication Holdings, Inc. Delivers Q2 Report with 298% Revenue Increase
Company Also Executes on New Software Platform and Note Settlements
PLEASANT HILL, CA / ACCESSWIRE / August 16, 2017 / Textmunication Holdings, Inc. (OTC PINK: TXHD), a cloud-based mobile SMS marketing platform provider, filed its 2017 2nd Quarter report on August 16, 2017. Textmunication reported a 298% revenue increase from $103,449 in Q2 2016 to $307,788 in Q2 2017.
The 298% revenue increase in this report was preceded by a 259% increase in the Q1 2017 filing. Textmunication has executed on its 2017 blueprint by increasing revenues, building technology infrastructure, and reducing toxic convertible notes.
In addition to growing revenues and settling notes, Textmunication is in the process of building its robust GEN3 SMS software platform. The company has used its resources, both financially and through the hiring of top-talent, building-out software and hardware infrastructure capable of growing with the fast-moving SMS sector. Textmunication's GEN3 platform was built for growth and speed. The new state-of-the-art platform can send more than 1B texts per month. This is a transformational shift for Textmunication as it builds for future expansion and new revenue opportunities.
SMS marketing has reached a level never seen before. According to a recent Mobile Marketing Watch article, industry analysts are reporting SMS is set to grow from $55.49 billion this year to $71.60 billion by 2021. The same article states the average smartphone user in the U.S. is downloading "zero" apps per month. Businesses of all sizes are looking to new forms of targeted advertising allowing consumers to opt-in and receive promotions, mobile coupons and notifications. Mobile apps are embedded on cell phones and often not used, while SMS communication alerts are read 97% of the time - typically within 3 minutes.
"Our focus has been building a new robust software platform capable of growing without limitations on platform capacity or speed," stated Textmunication CEO, Wais Asefi. "We are confident we've built a scalable platform rivaling any platform in the mobile marketing sector. Our new platform will be valued with the industry giants since it's capable of sending more texts than any platform we are aware of in the SMS sector."
SMS Software Platform
The GEN3 software platform has the capacity, speed and functionality to compete with the top SMS companies in a multi-billion market. Phase one migration of clients began in late June. Full migration is expected by early Q4. The new platform also provides API integration for clients wanting seamless sharing of data maximizing campaign results and efficiency. Textmunication's new White Label program will benefit with GEN3 by offering existing and new clients access to an "out-of-the-box" solution with speed to market and low start-up costs.
Textmunication offers White Label solutions and Direct API partnerships. Textmunication can now compete against industry giants such as Twilio for direct API opportunities. Textmunication has partnerships with the six largest Health Club Management Software firms. SalonTouch Studio, the number one recommended salon management software in the tanning industry, is also a valued partner for its thousands of clients. Several new white Label and Direct API partners are pending. Announcements will be made once each deal is finalized. Textmunication will also license its technology to strategic clients - including a large opportunity expected to close later this year in the Human Capital Management sector.
Note Settlements
Since late May, financial settlements were finalized with four major noteholders - comprising most of Textmunication's past due debt. All litigation has been resolved except for one outstanding case.
The company settled for fixed shares and leak-out provisions as part of the recent note settlements. The agreements provide the exact number of shares to be converted versus having conversions discounted to the market. The settlements were a major milestone providing financial clarity and balance sheet clean-up.
Aspire Consulting Group Executing Its Strategic Plan
Textmunication's sister-company, Aspire Consulting Group LLC ("Aspire", is gaining traction on its government contracting operation in Washington, D.C. Aspire was placed on a strategic team for Centers for Medicare and Medicaid Services (CMS) SPARC contract in March. The Service-Disabled Veteran-Owned (SDVOSB) task orders for SPARQ are coming out later this fall. This is a long-term contract supporting new federal healthcare initiatives. Aspire has established partnerships with several well-known System Integrators (SI) allowing for leverage and scalability in government contracting opportunities. Aspire now has teaming agreements with firms totaling more than $70B in combined annual revenue - including many of the leading IT Services firms in the D.C. market.
Aspire is well positioned with six active proposals awaiting award notification. Each contract offers significant revenue opportunities and long-term growth on some of the nation's most mission-critical programs. Revenue projections will be announced following each award. Textmunication has a 49% ownership stake in Aspire.
Aspire Consulting Group LLC: www.aspire.consulting
Text TXHD to shortcode 87365 to sign-up for news alerts and announcements via SMS.
About Textmunication Holdings, Inc.
Textmunication is an online mobile marketing platform service provider that helps health clubs, martial arts studios, salons and healthcare firms communicate with their members by allowing them to build loyalty, engage member retention, and create new business through a non-intrusive, value added medium. Textmunication connects members to the content they desire through any mobile device for health clubs and salon events, as well as promotions. Clients can send the most up-to-date offers, discounts, member alerts, events, PT schedules, or any other personalized campaign (www.textmunication.com).
Safe Harbor Provision:
Except for the statements of historical fact contained herein, the information presented in this news release constitutes "forward-looking statements" made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on any forward-looking statements in this press release as they reflect Textmunication Holdings' current expectations with respect to future events and are subject to risks and uncertainties that may cause actual results to differ materially from those contemplated. Potential risks and uncertainties include, but are not limited to, the risks described in Textmunication Holdings' filings with the Securities and Exchange Commission. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and any document referred to in this press release.
Contact:
Wais Asefi, CEO
Textmunication Holdings, Inc.
(800) 677-7003
wais@textmunication.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 446

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 333

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 38

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 90

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 104

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

SOCi's AI Marketing: Leading G2's Summer 2026 Rankings

Updated Category News Views 12

AI's Rising Star in Enterprise Marketing Here's a tidbit worth chewing over your morning coffee: SOCi Inc., a name that's been buzzing in the enterprise circles, has nailed top spots in G2's Summer 2026 Report. We're talking about leading the charge in AI marketing and localized visibility, territories tough to crack unless you've got serious chops. In a world where...

Continue Reading
AI and the Future of Staffing: A Market Growth Story

Updated Category News Views 344

AI and the Future of Staffing: A Growth Story The staffing services market is on the verge of a major transformation, thanks in large part to advancements in Artificial Intelligence (AI). This evolution is projected to add an astounding USD 236.6 billion to the global staffing services market between 2024 and 2028. During this time, the market is expected to experience a...

Continue Reading
Optical Innovations Unite: OCC and Lightera's New Partnership

Updated Category News Views 317

Strategic Collaboration Between OCC and Lightera Optical Cable Corporation (NASDAQ: OCC) and Lightera, LLC are entering a significant partnership aimed at enhancing their product offerings primarily in the data center and enterprise sectors. This collaboration builds upon their long-term relationship, combining their strengths to create innovative optical connectivity...

Continue Reading
INFINOX Welcomes Artem Gonov as New Chief Technology Officer

Updated Category News Views 148

INFINOX Appoints Artem Gonov as Chief Technology Officer INFINOX, a globally recognized brokerage, has recently appointed Artem Gonov as its new Chief Technology Officer (CTO). This strategic move underlines the company's commitment to enhancing its technology landscape and providing exceptional platforms for its clients. Artem Gonov's Background and Expertise Mr. Gonov...

Continue Reading
George Medicines’ GMRx2 Sets New Standard for Hypertension Care

Updated Category News Views 126

George Medicines Introduces GMRx2 for Hypertension Management Recent findings published in The Lancet highlighted the promising results of a Phase III trial for GMRx2, a novel triple combination pill aimed at managing hypertension. Developed by George Medicines, this medication is making waves in the field of cardiovascular care as it demonstrates significant advancements...

Continue Reading